Skip to main content

Table 1 Demographics of the patients at the first qualifying scan for analysis.

From: On improvement in ejection fraction with iron chelation in thalassemia major and the risk of future heart failure

Baseline ejection fraction group 56%-62% 63%-70%
N 109 216
Age 26.6 (8.6) 26.6 (8.7)
Sex   
   Male N (%) 59 (54.1) 110 (53.4)
   Female N (%) 50 (45.9) 96 (46.6)
Ethnicity   
   Indian N (%) 31 (28.4) 56 (27.2)
   Greek N (%) 18 (16.5) 31 (15.1)
   Cypriot N (%) 17 (15.6) 30 (14.6)
   Pakistani/Bangladeshi N (%) 14 (12.8) 32 (14.8)
   Turkish/Arabic N (%) 12 (11.0) 18 (8.3)
   Italian/Romanian N (%) 6 (5.5) 12 (5.6)
   Chinese/Malay N (%) 5 (4.6) 4 (2.0)
   Unknown N (%) 7 (6.4) 20 (9.3)
Ferritin [ug/L] 2140 (1600) 2065 (1636)
Cardiac T2* [ms] 19.7 (13.3) 23.2 (13.8)
Liver T2* [ms] 4.5 (4.3) 5.1 (4.6)
LVEDV [mL] 132.1 (33.5) 128.3 (38.4)
LVESV [mL] 49.3 (19.9) 43.8 (19.0)
LVEF [%] 59.7 (1.8) 66.7 (2.3)
Treatment   
   DFO N (%) 72 (66.1) 109 (52.9)
   DFP N (%) 10 (9.2) 35 (17.0)
   DFX N (%) 3 (2.75) 6 (2.9)
   DFO + DFP N (%) 22 (20.2) 50 (24.3)
   DFO + DFX N (%) 1 (0.9) 0 (0)
   None N (%) 1 (0.9) 6 (2.9)
  1. shown as mean (SD) except where N (%) is shown
  2. LV-left ventricle, EDV-end-diastolic volume, ESV-end-systolic volume, EF-ejection fraction, DFO-deferoxamine, DFP-deferiprone, DFX-deferasirox.